In one paragraphArticle in American journal of physiology. Regulatory, integrative and comparative physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
4 authors.
Supaporn KulthineeDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States.ORCID 0000-0002-6327-0708 Victoria L NasciDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States.ORCID 0000-0002-1891-8974 David M PollockDivision of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.ORCID 0000-0002-0233-2362 Eman Y GoharDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States.ORCID 0000-0003-0988-6445 Funding
VANDERBILT NEPHROLOGY TRAINING PROGRAMT32DK007569 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRIS, RAYMOND C., IKIZLER, TALAT ALP · 1988 to 2024
$5.8MUnraveling the Impact of Estrogen Signaling on Postmenopausal HypertensionR01HL171122 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Eman Gohar · 2024 to 2026
$1.8MSex Differences in Renal Sodium HandlingR00DK119413 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GOHAR, EMAN · 2021 to 2023
$740kSex Differences in Renal Sodium HandlingK99DK119413 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GOHAR, EMAN · 2019 to 2020
$182kHHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL171122HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R00DK119413HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) T32DK007569NHLBI NIH HHS R01 HL171122NIDDK NIH HHS K99 DK119413NIDDK NIH HHS R00 DK119413NIDDK NIH HHS T32 DK007569
6 · The paper itselfAbstract
Estradiol activates the G protein-coupled estrogen receptor 1 (GPER1), which promotes natriuresis in female rats. Extracellular adenosine triphosphate (ATP) released via connexin 30 (Cx30) hemichannels activates purinergic P2Y
Indexed as
KidneyNatriuresisReceptors, G-Protein-CoupledReceptors, Purinergic P2Y2Adenosine TriphosphateAnimalsConnexinsEpithelial Sodium ChannelsFemaleMiceMice, Inbred C57BLMice, KnockoutOvariectomyRatsRats, Sprague-DawleyReceptors, EstrogenAdenosine TriphosphateConnexinsEpithelial Sodium ChannelsGPER1 protein, mouseGper1 protein, ratP2ry2 protein, ratReceptors, EstrogenReceptors, G-Protein-CoupledReceptors, Purinergic P2Y2ATPconnexinestrogenhypertensionpurinoceptor
Identifiers
PMID41419204
PMCPMC12829622
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390